We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+8.88%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$5B
AUM Growth
+$569M
(+13%)
Cap. Flow
+$104M
Cap. Flow
% of AUM
2.08%
Top 10 Holdings %
Top 10 Hldgs %
38.84%
Holding
3,762
New
251
Increased
1,450
Reduced
1,277
Closed
224
Avg Time Held Equity + Options
4.7
years
Top 10 Avg Time Held Equity + Options
2.9
years
Top 20 Avg Time Held Equity + Options
3.8
years
Avg Time Held Equity only
4.7
years
Top 10 Avg Time Held Equity only
2.9
years
Top 20 Avg Time Held Equity only
3.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$18.4M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$9.77M |
| 3 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$5.48M |
| 4 |
Microsoft
MSFT
|
+$4.93M |
| 5 |
Vanguard S&P 500 ETF
VOO
|
+$4.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Corcept Therapeutics
CORT
|
+$7.34M |
| 2 |
Starbucks
SBUX
|
+$4.7M |
| 3 |
iShares California Muni Bond ETF
CMF
|
+$3.3M |
| 4 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$2.63M |
| 5 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 46.71% |
| 2 | Technology | 17.21% |
| 3 | Healthcare | 9.68% |
| 4 | Financials | 7.2% |
| 5 | Communication Services | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3151
Embotelladora Andina Series B
AKO.B
$4.57B
| $1.09K | ﹤0.01% |
+45
| New | +$1.12K |
2025 Q2
0 quarters
|
|
3152
Provident Financial Services
PFS
$2.9B
| $1.08K | ﹤0.01% |
62
| – | – |
2024 Q2
4 quarters
|
|
3153
LeMaitre Vascular
LMAT
$1.9B
| $1.08K | ﹤0.01% |
13
+5
| +63% | +$418 |
2022 Q2
12 quarters
|
|
3154
TechTarget
TTGT
$287M
| $1.06K | ﹤0.01% |
+137
| New | +$1.09K |
2025 Q2
0 quarters
|
|
3155
Amneal Pharmaceuticals
AMRX
$6.7B
| $1.06K | ﹤0.01% |
131
| – | – |
2023 Q4
6 quarters
|
|
3156
NeoGenomics
NEO
$2.22B
| $1.05K | ﹤0.01% |
144
-96
| -40% | -$775 |
2021 Q1
17 quarters
|
|
3157
Krispy Kreme
DNUT
$538M
| $1.04K | ﹤0.01% |
+358
| New | +$1.25K |
2025 Q2
0 quarters
|
|
3158
DELISTED
Surmodics
SRDX
| $1.04K | ﹤0.01% |
35
-4
| -10% | -$115 |
2024 Q2
4 quarters
|
|
3159
Psyence Biomedical Warrant
PBMWW
$210K
| $1.01K | ﹤0.01% |
+50,000
| New | +$800 |
2025 Q2
0 quarters
|
|
3160
Garrett Motion
GTX
$4.56B
| $1.01K | ﹤0.01% |
96
| – | – |
2021 Q3
15 quarters
|
|
3161
Supernus Pharmaceuticals
SUPN
$2.3B
| $1.01K | ﹤0.01% |
32
+20
| +167% | +$641 |
2022 Q3
11 quarters
|
|
3162
RXO
RXO
$4.79B
| $1.01K | ﹤0.01% |
64
-128
| -67% | -$1.94K |
2022 Q4
10 quarters
|
|
3163
Quadratic Deflation ETF
BNDD
$13M
| $1K | ﹤0.01% |
10
| – | – |
2025 Q1
1 quarter
|
|
3164
DELISTED
REV Group
REVG
| $999 | ﹤0.01% |
21
| – | – |
2024 Q4
2 quarters
|
|
3165
Ultra Clean Holdings
UCTT
$2.53B
| $993 | ﹤0.01% |
44
-382
| -90% | -$7.84K |
2021 Q3
15 quarters
|
|
3166
BGC Group
BGC
$5.41B
| $992 | ﹤0.01% |
97
+40
| +70% | +$367 |
2023 Q4
6 quarters
|
|
3167
iShares Residential and Multisector Real Estate ETF
REZ
$795M
| $988 | ﹤0.01% |
+12
| New | +$989 |
2025 Q2
0 quarters
|
|
3168
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
$3.06B
| $987 | ﹤0.01% |
32
| – | – |
2018 Q2
28 quarters
|
|
3169
DELISTED
Jamf
JAMF
| $980 | ﹤0.01% |
103
| – | – |
2022 Q4
10 quarters
|
|
3170
XPLR Infrastructure LP
XIFR
$926M
| $980 | ﹤0.01% |
120
| – | – |
2021 Q4
14 quarters
|
|
3171
Franklin FTSE Japan ETF
FLJP
$4.19B
| $965 | ﹤0.01% |
30
| – | – |
2023 Q1
9 quarters
|
|
3172
Insperity
NSP
$1.94B
| $962 | ﹤0.01% |
16
-333
| -95% | -$23.3K |
2021 Q2
16 quarters
|
|
3173
Invesco KBW Premium Yield Equity REIT ETF
KBWY
$288M
| $960 | ﹤0.01% |
61
| – | – |
2017 Q1
33 quarters
|
|
3174
Bloomin' Brands
BLMN
$850M
| $950 | ﹤0.01% |
110
-231
| -68% | -$1.85K |
2025 Q1
1 quarter
|
|
3175
Central Garden & Pet Co
CENT
$2.63B
| $950 | ﹤0.01% |
27
| – | – |
2020 Q1
21 quarters
|
|
Similar funds
Parallel Advisors's Q2 2025 Portfolio in Review
As of Q2 2025, Parallel Advisors held 3,762 positions worth $5B, up 13% from $4.43B the previous quarter. Its ten largest holdings account for 39% of the portfolio.
Parallel Advisors's Q2 2025 filing shows 251 new, 1,450 increased, 1,277 reduced and 224 closed positions. Its largest new stake was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M. The largest sale was Corcept Therapeutics, an estimated $7.34M.
By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, down from 47% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2025 buy was Vanguard 0-3 Month Treasury Bill ETF: 32,722 shares worth $2.47M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2025, an estimated $18.4M increase.
- Parallel Advisors's biggest Q2 2025 reduction was Corcept Therapeutics, cutting an estimated $7.34M.
- Parallel Advisors fully exited Discover Financial Services in Q2 2025, selling an estimated $1.22M.
- Parallel Advisors's ten largest holdings make up 39% of its $5B portfolio in Q2 2025.
- Parallel Advisors opened 251 new positions and closed 224 in Q2 2025.
- Parallel Advisors's portfolio value rose 13% quarter-over-quarter to $5B.
Based on Parallel Advisors's 13F filing for Q2 2025, filed 8 Jul 2025.